Сравнение

Buserelin vs. Terlipressin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

57982-77-1

14636-12-5

Молекулярная масса

1239.42 g/mol

1227.37 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Buserelin	Terlipressin
Германия	Рецептурный	Рецептурный
США	Не одобрено	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Buserelin and Terlipressin?: Buserelin is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Terlipressin?: The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Terlipressin in Germany and the United States?: Германия: Buserelin — Рецептурный, Terlipressin — Рецептурный. США: Buserelin — Не одобрено, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Terlipressin

Германия

Рецептурный

США

Не одобрено

Рецептурный

Frequently asked questions

What is the difference between Buserelin and Terlipressin?

Buserelin is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Terlipressin?

The highest available evidence level is "РКИ на людях" for Buserelin and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Terlipressin in Germany and the United States?

Германия: Buserelin — Рецептурный, Terlipressin — Рецептурный. США: Buserelin — Не одобрено, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.